In this issue:
Efficacy of fruquintinib plus paclitaxel
The safety and efficacy of nivolumab and chemotherapy
Evaluation of camrelizumab plus SOX
FOLFIRI as second-line treatment
Optimal SMI cutoff
Effect of TP53 status on clinical outcomes
Impact of trastuzumab on immune cells
Staging laparoscopy
Survival outcomes of TNT
5-FU bolus and survival impact
Please login below to download this issue (PDF)